A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy Journal Article
| Authors: | Haas, G. P.; Scher, H. I. |
| Article Title: | A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy |
| Keywords: | treatment response; quality control; editorial; tumor marker; cancer research; cancer therapy; prediction; urinary tract cancer; androgen receptor; gonadorelin agonist; toxicity; castration resistant prostate cancer; point of care testing; human; priority journal |
| Journal Title: | Urologic Oncology: Seminars and Original Investigations |
| Volume: | 33 |
| Issue: | 6 |
| ISSN: | 1078-1439 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-06-01 |
| Start Page: | 269 |
| Language: | English |
| DOI: | 10.1016/j.urolonc.2015.01.026 |
| PROVIDER: | scopus |
| PUBMED: | 25817318 |
| DOI/URL: | |
| Notes: | Export Date: 2 July 2015 -- Source: Scopus |
